Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

NCT06042517 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06042517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06042517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2023
Completion date
September 30, 2027
Enrollment
77 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin sensitivity